{
  "actions": [
    {
      "acted_at": "2023-05-11",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2023-05-11",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2023-05-11",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2023-05-12",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2024-12-17",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr3248-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "02"
    },
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "D000197",
      "district": "1",
      "name": "DeGette, Diana",
      "original_cosponsor": true,
      "sponsored_at": "2023-05-11",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-05-11",
  "number": "3248",
  "official_title": "To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr3561-118",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Diagnostic Lab Testing Transparency Act",
  "sponsor": {
    "bioguide_id": "M001215",
    "district": "1",
    "name": "Miller-Meeks, Mariannette",
    "state": "IA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-05-11",
  "subjects": [
    "Civil actions and liability",
    "Health",
    "Health care costs and insurance",
    "Medical tests and diagnostic methods"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2023-05-11",
    "date": "2024-01-12T19:20:00Z",
    "text": "Diagnostic Lab Testing Transparency Act\n\nThis bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.\n\nSpecifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Diagnostic Lab Testing Transparency Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Diagnostic Lab Testing Transparency Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.",
      "type": "official"
    }
  ],
  "updated_at": "2025-05-27T14:12:59Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr3248.xml"
}